Natco Pharma Rights Issue closes today, size up to Rs 1,279 cr

Corporate Actions View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹784.00

prior close

₹782.30

announcement price

In-mkt

timing

Nifty Smallcap 250market-1.1%+1.3% vs market

Pharmaceuticals peers, median of 170sector-0.5%+0.8% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Smallcap 250 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.1

15m

+0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2-1.1+1.3-0.5+0.8

Next day

+0.8-3.9+4.6-2.2+3.0

+1.1-2.8+3.9-1.1+2.2

+1.8-0.6+2.4+0.7+1.1

+1.0pendingpending+1.9-0.9

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma's rights issue closed on October 22, 2026. The company offered equity shares of face value Rs 2 at Rs 750 each, aiming to raise up to Rs 1,279 crores. The issue opened on October 12 and was approved by the board on September 25, 2026.

Likely market impact

Shareholders who did not subscribe may see dilution. Allotment and subscription details will follow, impacting shareholding pattern.